Krka Logo

Krka

An international generic pharmaceutical company developing human and animal health products.

KRKG | LJSE

Overview

Corporate Details

ISIN(s):
SI0031102120
LEI:
549300H9RLRTRTLRUZ73
Country:
Slovenia
Address:
Šmarješka cesta 006, 8501 Novo mesto

Description

Krka is an international generic pharmaceutical company engaged in the development, production, marketing, and sales of human and animal health products. The company's core business is focused on generic prescription pharmaceuticals, which it markets under its own brands. Its product portfolio is complemented by a range of non-prescription products and a comprehensive line of animal health products. With a history spanning over 70 years, Krka is committed to providing high-quality, effective, and safe products to a global market, aiming to contribute to a better quality of life.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-23 08:30
Podrobno poročilo o nakupih lastnih delnic
English 124.5 KB
2025-12-23 08:30
Pridobivanje lastnih delnic
Slovene 2.3 KB
2025-12-23 08:30
Detailed report on acquisition of treasury shares
English 127.2 KB
2025-12-23 08:30
Acquisition of treasury shares
English 2.4 KB
2025-12-22 08:53
Detailed report on acquisition of treasury shares
English 127.2 KB
2025-12-15 08:30
Detailed report on acquisition of treasury shares
English 118.0 KB
2025-12-15 08:30
Acquisition of treasury shares
English 2.3 KB
2025-12-15 08:30
Podrobno poročilo o nakupih lastnih delnic
English 115.5 KB
2025-12-15 08:30
Pridobivanje lastnih delnic
Slovene 2.2 KB
2025-12-12 12:53
Detailed report on acquisition of treasury shares
English 118.0 KB
2025-12-08 08:30
Detailed report on acquisition of treasury shares
English 127.7 KB
2025-12-08 08:30
Acquisition of treasury shares
English 2.3 KB
2025-12-08 08:30
Podrobno poročilo o nakupih lastnih delnic
English 125.3 KB
2025-12-08 08:30
Pridobivanje lastnih delnic
Slovene 2.2 KB
2025-12-05 08:30
Krka receives new S&P Global CSA Score
English 2.5 KB

Automate Your Workflow. Get a real-time feed of all Krka filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Krka

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Krka via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Acurx Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing a new class of antibiotics for priority pathogens.
United States of America
ACXP
Adaptimmune Therapeutics PLC Logo
Commercial-stage biopharma developing TCR T-cell therapies for solid tumors.
United States of America
ADAP
ADBIOTECH Co.,Ltd. Logo
Develops IgY-based immune antibodies as alternatives to vaccines and antibiotics.
South Korea
179530
ADC Therapeutics SA Logo
Commercial-stage biotech developing antibody-drug conjugates for cancer therapy.
United States of America
ADCT
Addex Therapeutics Ltd. Logo
Clinical-stage biopharma developing allosteric modulators for neurological disorders.
Switzerland
ADXN
ADIAL PHARMACEUTICALS, INC. Logo
A clinical-stage biopharma developing genetically targeted therapies for addiction.
United States of America
ADIL
Adicet Bio, Inc. Logo
Develops allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.
United States of America
ACET
Adlai Nortye Ltd. Logo
A clinical-stage biopharma firm developing cancer immunotherapies and RAS-targeting drugs.
United States of America
ANL
ADMA BIOLOGICS, INC. Logo
Biopharmaceutical company that develops and manufactures plasma-derived biologics.
United States of America
ADMA
Adverum Biotechnologies, Inc. Logo
A clinical-stage company developing gene therapies for ocular diseases.
United States of America
ADVM

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.